View in EDS

Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases.

Saved in:
Bibliographic Details
Title: Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases.
Authors: Vokes, E E1 evokes@medicine.bsd.uchicago.edu, Ready, N2, Felip, E3, Horn, L4, Burgio, M A5, Antonia, S J6, Frontera, O Arén7, Gettinger, S8, Holgado, E9, Spigel, D10
Source: Annals of Oncology. Apr2018, Vol. 29 Issue 4, p959-965. 7p. 2 Charts, 2 Graphs.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1093/annonc/mdy041